Your own stem cells can help treat heart disease: StudyNovember 18th, 2009 WASHINGTON - Transplanting own stem cells into heart of severe angina patients lessens their pain and improves their ability to walk, a new study has revealed. The largest national stem cell study for heart disease showed that transplant subjects also experienced fewer deaths than those who didn't receive stem cells.
Two units of umbilical cord blood 'reduce leukemia recurrence risk'November 14th, 2009 WASHINGTON - If patients with acute leukaemia are transplanted with two units of umbilical cord blood (UCB), their risk of the disease recurrence is significantly reduced, according to a new study from the Masonic Cancer Center, University of Minnesota. The finding could change the current medical practice of using one unit of UCB for treatment of patients who are at high risk for recurrence of leukaemia and other cancers of the blood and bone marrow.
New stem cell treatment raises hope for people with cervical damageNovember 10th, 2009 WASHINGTON - The first human embryonic stem cell treatment for human testing shows promise in helping people with cervical damage after restoring limb function in rats with neck spinal cord injuries. Researchers at University of California, Irvine, found that the walking ability of the rats that were treated with the stem cell therapy was restored to 97 percent.
Scientists create lung tissue from human embryonic stem cellsNovember 5th, 2009 WASHINGTON - In a breakthrough study, scientists from Free University of Brussels, Belgium have successfully created lung tissue with human embryonic stem cells. The new discovery would provide an alternative to lung transplants patients with lung injury due to chronic pulmonary disease and inherited genetic diseases such as cystic fibrosis.
CordLife targets India as potential stem cell marketNovember 4th, 2009 KOLKATA - CordLife, one of the leading stem cell banking groups in the Asia Pacific region, is targeting expansion of its network in India and China, considering the huge birth rate in these two Asian nations, a top official said Wednesday. "We're looking at India and China as two big markets in terms of our stem cell business in the Asia Pacific region - keeping in mind the huge birth rate in these two countries," CordLife group chief executive Steven Fang told IANS Wednesday on the sidelines of a press conference here.
Targeted immunotherapy may help treat lymphomaOctober 31st, 2009 WASHINGTON - A new study has revealed that targeted immunotherapy has been found effective in treating lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a hematopoietic stem cell transplant (HSCT). Lymphoma is a cancer of white blood cells called lymphocytes that are largely responsible for maintaining the body's immunity, and EBV is one of the most common human viruses that can have a long-lasting impact on the body's immune system.
Acute lung injury? Stem cell therapy may helpOctober 30th, 2009 WASHINGTON - Researchers have shown that adult stem cells from bone marrow can prevent acute lung injury in a mouse model of the disease. The study was conducted by researchers at the University of Illinois at the Chicago College of Medicine.
Stem cell therapy holds promise for acute lung injuryOctober 29th, 2009 WASHINGTON - A new study in mice, conducted by researchers at the University of Illinois at Chicago College of Medicine, has shown that adult stem cells from bone marrow can help treat acute lung injury. Acute lung injury (ALI) can be caused by any major inflammation or injury to the lungs and is a major cause of death in patients in hospital ICUs.
Stem cell-based therapy offers new hope for kidney disease patientsOctober 16th, 2009 WASHINGTON - Researchers have suggested that several stem cell based therapies can help treat patients with Alport syndrome. Most often occurring in boys, Alport syndrome causes progressive kidney disease leading to kidney failure at a young age.
A step toward future heart repair: Using mice stem cells to grow beating strip of heart muscleOctober 15th, 2009 Scientists grow mice heart muscle strip that beatsWASHINGTON — Scientists have grown a piece of heart muscle — and then watched it beat — by using stem cells from a mouse embryo, a big step toward one day repairing damage from heart attacks. Think of Dr.
World's first 'artificial heart-stem cells' combo op saves a lifeSeptember 25th, 2009 LONDON - A British surgeon has for the first time used a combination of an artificial heart and stem cells to save the life of a dying man. Professor Stephen Westaby, based at the John Radcliffe Hospital in Oxford, led the team that operated on Ioannis Manolopoulos in Thessaloniki, Greece, to fit him with the mechanical pump because his heart was too weak to push blood around his body.
Stem cell studies pave way for novel bone repair pastesSeptember 23rd, 2009 WASHINGTON - Researchers at the University of Maryland Dental School have conducted new stem cell studies that may pave the way for the use of strong, mouldable, and injectable pastes to regenerate needed bone tissue to repair broken bones, fractures, genetic defects, even combat bone wounds. Dr. Huakun Xu, Dr.
Master gene that switches on disease-fighting cells identifiedSeptember 14th, 2009 LONDON - British scientists have identified the master gene, called E4bp4, that causes blood stem cells to turn into disease-fighting 'Natural Killer' (NK) immune cells. The discovery, by researchers at Imperial College London, UCL and the Medical Research Council's National Institute for Medical Research, could one day help scientists boost the body's production of these frontline tumour-killing cells, creating new ways to treat cancer.
Max New York Life Insurance ties up with LifeCell InternationalSeptember 9th, 2009 NEW DELHI - Max New York Life Insurance Co. Ltd, one of India's leading insurance companies today announced a strategic tie up with LifeCell International ("LifeCell") India's first and the largest stem cell banking service provider, and a pioneer in stem cell research and technology.
Turning off oncogene may inhibit lung cancer stem cells' growthSeptember 9th, 2009 WASHINGTON - A lung cancer oncogene, called PKCiota, is necessary for the proliferation of lung cancer stem cells, and turning it off could act as a key for the treatment of this deadly disease, according to scientists at the Mayo Clinic campus in Florida. These stem cells are rare and powerful master cells that manufacture the other cells that make up lung tumours, and are resistant to chemotherapy treatment.
